Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home AI & Quantum Computing

AMD Shares Gain Momentum as Wall Street Boosts Price Targets

Robert Sasse by Robert Sasse
September 23, 2025
in AI & Quantum Computing, Analysis, Nasdaq, Semiconductors, Tech & Software
0
AMD Stock
0
SHARES
311
VIEWS
Share on FacebookShare on Twitter

Wall Street analysts are expressing growing confidence in Advanced Micro Devices (AMD), with two major investment banks significantly raising their price targets for the chipmaker. This optimistic stance is driven by AMD’s strategic focus on artificial intelligence, even as the company navigates significant geopolitical trade restrictions.

Strong Quarterly Results Underpin Analyst Confidence

The positive outlook from financial institutions is grounded in AMD’s impressive second-quarter performance for fiscal 2025. The company reported a record $7.7 billion in revenue, representing a substantial 32% year-over-year increase. A breakdown of the results reveals powerful growth across key segments:
– The Data Center business expanded by 14%, reaching $3.2 billion.
– The Client and Gaming segment experienced a remarkable surge, growing 69% to $3.6 billion.

Notably, these results were achieved despite absorbing an $800 million charge related to export restrictions on AI chips destined for China. CEO Lisa Su underscored the company’s position, stating, “We are seeing robust demand across our entire computing and AI product portfolio.”

Investment Banks Raise the Bar

Bank of America issued the most bullish forecast, setting a price target of $200 per share for AMD, which implies significant upside potential from current trading levels. The bank’s analysts specifically pointed to AI-driven growth and market share gains in processors as primary catalysts. In a similarly optimistic move, TD Cowen increased its price target from $165 to $195, while maintaining its buy recommendation. This collective action signals strong and continued faith in the strategic direction set by CEO Lisa Su.

Should investors sell immediately? Or is it worth buying AMD?

AMD Challenges NVIDIA’s AI Dominance

The company is rapidly positioning itself as a formidable competitor to NVIDIA in the lucrative AI chip market. Its Instinct MI350 accelerators are gaining traction with major hyperscale clients, including Meta, Microsoft, and Oracle. Furthermore, AMD is directly addressing NVIDIA’s software advantage with its ROCm 7 software platform, a key element in its competitive strategy.

However, challenges persist. US export controls on advanced AI chips to China are projected to result in a substantial revenue shortfall of $1.5 billion in 2025. The company has already ceased planned shipments of its MI308 chips to the Chinese market for the third quarter.

Future Catalysts and Market Expectations

A potential major catalyst for the stock is scheduled for November 11, 2025, when AMD hosts its Financial Analyst Day. Should the company’s management confirm ambitious AI revenue projections during this event, it could further validate the recent wave of analyst optimism. Current consensus price targets for AMD shares already range from $174 to $200.

The central question for investors remains whether AMD can meet these elevated expectations and successfully cement its role as a strong secondary player in the high-stakes AI market, all while overcoming ongoing geopolitical headwinds.

Ad

AMD Stock: Buy or Sell?! New AMD Analysis from March 25 delivers the answer:

The latest AMD figures speak for themselves: Urgent action needed for AMD investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

AMD: Buy or sell? Read more here...

Tags: AMD
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

ImmunityBio Stock
Analysis

Regulatory Rebuke Sends ImmunityBio Shares Tumbling

March 25, 2026
IBM Stock
Analysis

IBM Shares Face Pressure from Analyst Downgrades and Acquisition Concerns

March 25, 2026
Coeur Mining Stock
Analysis

Divergent Analyst Views Highlight Coeur Mining’s Strategic Transition

March 25, 2026
Next Post
National Health Investors Stock

National Health Investors Secures $350 Million Through Bond Offering to Strengthen Financial Position

Yum China Stock

Can Yum China's Shareholder Returns Strategy Revive Its Stock?

Archer-Daniels-Midland Stock

Archer-Daniels-Midland Shares Face Pressure from Technical and Fundamental Headwinds

Recommended

Thyssenkrupp Stock

Thyssenkrupp’s Restructuring Plan Faces Critical Test

1 week ago
Almonty Stock

Almonty’s Strategic Pivot: From Defense to Fusion Energy

2 months ago
Stride Stock

Stride Faces Investor Backlash Following Platform Failure

4 months ago
Finance_Commercial (2)

Cadre Holdings Announces Public Offering of Common Stock

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Battalion Oil Navigates Debt and Operational Overhaul

Divergent Analyst Views Highlight Coeur Mining’s Strategic Transition

Rocket Lab Stock Attracts Bullish Analyst Sentiment Amid Growth Trajectory

TSMC’s Arizona Expansion Gains Momentum Amid Record Retail Investor Interest

Salesforce Shares Face Pressure from External AI Innovation

UnitedHealth Bets on Artificial Intelligence to Counteract Mounting Pressures

Trending

ImmunityBio Stock
Analysis

Regulatory Rebuke Sends ImmunityBio Shares Tumbling

by Rodolfo Hanigan
March 25, 2026
0

A significant regulatory warning from the U.S. Food and Drug Administration (FDA) has triggered a sharp sell-off...

Realty Income Stock

Realty Income’s Strategic Financing Defies High Interest Rate Environment

March 25, 2026
IBM Stock

IBM Shares Face Pressure from Analyst Downgrades and Acquisition Concerns

March 25, 2026
Battalion Oil Stock

Battalion Oil Navigates Debt and Operational Overhaul

March 25, 2026
Coeur Mining Stock

Divergent Analyst Views Highlight Coeur Mining’s Strategic Transition

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Regulatory Rebuke Sends ImmunityBio Shares Tumbling
  • Realty Income’s Strategic Financing Defies High Interest Rate Environment
  • IBM Shares Face Pressure from Analyst Downgrades and Acquisition Concerns

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com